
    
      This was a prospective, randomized, double-blind, placebo-controlled, study. Subjects were
      randomized to receive either CAIV-T or Placebo. All subjects were healthy children and
      adolescents aged at least 6 years of age and less than 18 years of age at the time of
      enrollment.
    
  